HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Lymphogranuloma Venereum

Subacute inflammation of the inguinal lymph glands caused by certain immunotypes of CHLAMYDIA TRACHOMATIS. It is a sexually transmitted disease in the U.S. but is more widespread in developing countries. It is distinguished from granuloma venereum (see GRANULOMA INGUINALE), which is caused by Calymmatobacterium granulomatis.
Also Known As:
Lymphogranuloma Inguinale
Networked: 214 relevant articles (4 outcomes, 24 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Urethritis
2. Uterine Cervicitis (Cervicitis)
3. Infection
4. Neurosyphilis (General Paresis of the Insane)
5. Hepatitis C

Experts

1. Morré, Servaas A: 3 articles (12/2010 - 02/2008)
2. de Vries, Henry J C: 3 articles (12/2010 - 02/2008)
3. Borrego, Maria José: 2 articles (01/2014 - 12/2012)
4. Ferreira, Rita: 2 articles (01/2014 - 12/2012)
5. Borges, Vítor: 2 articles (01/2014 - 12/2012)
6. Gomes, João Paulo: 2 articles (01/2014 - 12/2012)
7. Ojcius, David M: 2 articles (01/2011 - 11/2004)
8. Workowski, Kimberly A: 2 articles (12/2010 - 08/2006)
9. Smelov, Vitaly: 2 articles (12/2010 - 03/2009)
10. Pleijster, Jolein: 2 articles (12/2010 - 03/2009)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Lymphogranuloma Venereum:
1. Azithromycin (Zithromax)FDA LinkGeneric
12/01/2003 - "Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin."
01/01/1996 - "In both series, azithromycin treatment resulted in cure of both Haemophilus ducreyi culture-positive and culture-negative cases of GUD, including two cases subsequently diagnosed as lymphogranuloma venereum. "
08/04/2006 - "Included in these updated guidelines are an expanded diagnostic evaluation for cervicitis and trichomoniasis; new antimicrobial recommendations for trichomoniasis; additional data on the clinical efficacy of azithromycin for chlamydial infections in pregnancy; discussion of the role of Mycoplasma genitalium and trichomoniasis in urethritis/cervicitis and treatment-related implications; emergence of lymphogranuloma venereum protocolitis among men who have sex with men (MSM); expanded discussion of the criteria for spinal fluid examination to evaluate for neurosyphilis; the emergence of azithromycin- resistant Treponema pallidum; increasing prevalence of quinolone-resistant Neisseria gonorrhoeae in MSM; revised discussion concerning the sexual transmission of hepatitis C; postexposure prophylaxis after sexual assault; and an expanded discussion of STD prevention approaches."
12/17/2010 - "Included in these updated guidelines is new information regarding 1) the expanded diagnostic evaluation for cervicitis and trichomoniasis; 2) new treatment recommendations for bacterial vaginosis and genital warts; 3) the clinical efficacy of azithromycin for chlamydial infections in pregnancy; 4) the role of Mycoplasma genitalium and trichomoniasis in urethritis/cervicitis and treatment-related implications; 5) lymphogranuloma venereum proctocolitis among men who have sex with men; 6) the criteria for spinal fluid examination to evaluate for neurosyphilis; 7) the emergence of azithromycin-resistant Treponema pallidum; 8) the increasing prevalence of antimicrobial-resistant Neisseria gonorrhoeae; 9) the sexual transmission of hepatitis C; 10) diagnostic evaluation after sexual assault; and 11) STD prevention approaches."
04/01/2015 - "This article addresses factors that may be contributing to treatment failure for rectal chlamydia, including the pharmacokinetic properties of azithromycin and doxycycline in rectal tissue, the ability of chlamydia to transform into a persistent state that is less responsive to antimicrobial therapy, the impact of the rectal microbiome on chlamydia, heterotypic resistance, failure to detect cases of lymphogranuloma venereum and the performance of screening tests. "
2. Chlortetracycline (Aureomycin)FDA Link
3. Immunoglobulin G (IgG)IBA
4. Immunoglobulin M (IgM)IBA
5. Complement System Proteins (Complement)IBA
6. AntigensIBA
7. Anti-Bacterial Agents (Antibiotics)IBA
8. SolventsIBA
9. Doxycycline (Vibramycin)FDA LinkGeneric
10. Oxytetracycline (Terramycin)FDA Link

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Aftercare (After-Treatment)
3. Injections
4. Hysterectomy
5. Enema (Enemas)